InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

- Current share price for ARX : $0.495

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$171 Change of Director's Interest Notice - CM 14 Aug 2023 2:45PM $0.885 $0.495 fallen by 44.07%
$171 Notification regarding unquoted securities - ARX 14 Aug 2023 2:41PM $0.885 $0.495 fallen by 44.07%
$171 Results of Annual General Meeting 3 Aug 2023 5:29PM $0.910 $0.495 fallen by 45.60%
$171 CEO Presentation - AGM 3 Aug 2023 11:49AM $0.900 $0.495 fallen by 45%
$171 Chairman's Address - AGM 3 Aug 2023 11:45AM $0.900 $0.495 fallen by 45%
$171 June 2023 Quarterly Report and Appendix 4C 31 Jul 2023 8:44AM $0.910 $0.495 fallen by 45.60%
$171 Notification of Quarterly Results Webinar 24 Jul 2023 9:00AM $0.920 $0.495 fallen by 46.20%
$171 Notification of cessation of securities - ARX 14 Jul 2023 10:01AM $0.900 $0.495 fallen by 45%
$171 Notice of Annual General Meeting/Proxy Form 10 Jul 2023 1:08PM $0.890 $0.495 fallen by 44.38%
$171 Appendix 4G and Corporate Governance Statement 30 Jun 2023 9:10AM $0.895 $0.495 fallen by 44.69%
$171 Annual Report to Shareholders 30 Jun 2023 9:09AM $0.895 $0.495 fallen by 44.69%
$171 Notice of AGM Date and Director Nomination Closing Date 7 Jun 2023 2:33PM $0.883 $0.495 fallen by 43.91%
$171 Investor Presentation 1 Jun 2023 9:50AM $0.935 $0.495 fallen by 47.06%
$171 FY23 Full Year Results Presentation 31 May 2023 8:41AM $1.010 $0.495 fallen by 50.99%
$171 FY23 Appendix 4E and Full Year Results 31 May 2023 8:40AM $1.010 $0.495 fallen by 50.99%
$171 Notification of Full Year Results Webinar 24 May 2023 8:47AM $0.920 $0.495 fallen by 46.20%
$171 Investor Presentation 27 Apr 2023 8:41AM $1.010 $0.495 fallen by 50.99%
$171 March 2023 Quarterly Report and Appendix 4C 27 Apr 2023 8:39AM $1.010 $0.495 fallen by 50.99%
$171 Notification of Quarterly Results Webinar 20 Apr 2023 8:39AM $1.050 $0.495 fallen by 52.86%
$171 Notification regarding unquoted securities - ARX 12 Apr 2023 12:50PM $1.050 $0.495 fallen by 52.86%
$171 AROA secures first FDA clearance for ENIVO system 12 Apr 2023 9:05AM $1.060 $0.495 fallen by 53.30%
$171 Release of Shares from Voluntary Escrow 4 Apr 2023 12:49PM $1.075 $0.495 fallen by 53.95%
$171 Change of Director's Interest Notice - SE 31 Mar 2023 2:50PM $1.060 $0.495 fallen by 53.30%
$171 Change of Director's Interest Notice - JP 31 Mar 2023 2:48PM $1.060 $0.495 fallen by 53.30%
$171 Change of Director's Interest Notice - JM 31 Mar 2023 2:46PM $1.060 $0.495 fallen by 53.30%

176 - 200 of 777 results

Page 8 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.